Davunetide (Nap, Al 108) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Davunetide (NAP) is an octapeptide derived from the activity-dependent neuroprotective protein (ADNP) that promotes microtubule stability and neuroprotection in Alzheimer's disease and other neurodegenerative conditions. [@phase2021]
Davunetide (Nap, Al 108) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Davunetide (NAP) is an octapeptide derived from the activity-dependent neuroprotective protein (ADNP) that promotes microtubule stability and neuroprotection in Alzheimer's disease and other neurodegenerative conditions. [@phase2021]
Overview
Mechanism of Action
Davunetide is an 8-amino acid peptide (NAPVSIPQ) that provides neuroprotection through multiple mechanisms:
1. Microtubule Stabilization
Binds to tubulin and promotes microtubule assembly
Protects against [tau](/proteins/tau)-induced microtubule dysfunction
Restores axonal transport in degenerating [neurons](/entities/neurons)
2. Anti-Apoptotic Effects
Activates survival pathways (PI3K/Akt, MAPK/ERK)
Inhibits caspase-3 activation
Reduces mitochondrial dysfunction
3. Anti-Inflammatory Activity
Reduces glial activation
Decreases pro-inflammatory cytokine release
Modulates neuroimmune responses
4. Synaptic Protection
Preserves synaptic structure and function
Enhances dendritic spine density
Improves [LTP](/mechanisms/long-term-potentiation) and memory formation
Clinical Development
Phase 1 Studies
Single and multiple ascending dose studies
Demonstrated safety and tolerability
Good brain penetration with intranasal delivery
Dose selection for Phase 2
Phase 2 Study (MIDIA)
12-month trial in patients with mild cognitive impairment
Primary endpoint: Cognitive function (ADAS-Cog)
Showed significant benefit in executive function
Greater benefit in patients with higher biomarker levels
The study of Davunetide (Nap, Al 108) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Allen Brain Atlas Resources
[Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions